Publication | Closed Access

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Tumor BiologyMedicinePathologyBronchial NeoplasmCancer BiologyHistomolecular Resistance MechanismsCancer GeneticsFirst-line OsimertinibOncologyCell BiologyLung CancerCancer Research